June 28, 2022 June 28, 2022Categories Announcements News StoriesThe Summer 2022 advocacy blog, Considering Clinical Trials, is now available
June 22, 2022 June 22, 2022Categories News StoriesFDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH
June 20, 2022 June 20, 2022Categories News StoriesTMIST breast cancer trial looks to recruit underserved communities
June 7, 2022 June 7, 2022Categories News StoriesPancreatic neuroendocrine tumors: Capecitabine plus temozolomide gives longer PFS than temozolomide alone
June 7, 2022 June 7, 2022Categories News StoriesE2108 evidence informs a discussion on systemic therapy vs surgery for de novo stage IV breast cancer
June 6, 2022 June 6, 2022Categories News StoriesNovel drug combination demonstrates promising results in treating pancreatic neuroendocrine tumors
June 6, 2022 June 6, 2022Categories News StoriesE2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors
June 6, 2022 June 6, 2022Categories News StoriesDr. Michael Atkins discusses the DREAMseq trial in patients with advanced melanoma
June 5, 2022 June 5, 2022Categories News StoriesDr. Pamela Kunz on pancreatic neuroendocrine tumors: A final analysis of temozolomide or temozolomide plus capecitabine
June 5, 2022 June 5, 2022Categories News StoriesDrug combination shows promise for treating pancreatic neuroendocrine tumors
June 4, 2022 June 4, 2022Categories News StoriesE3311: No differences in survival outcomes based on tobacco history in HPV-associated head and neck cancer
June 1, 2022 June 1, 2022Categories News StoriesPrecision medicine clinical trials: A conversation between Peter O’Dwyer and Lale Kostakoglu
